Alefacept in the Treatment of Psoriatic Nail Disease: A Proof of Concept Study
April 2006 | Volume 5 | Issue 4 | Original Article | 339 | Copyright © April 2006
Charles A. Parrish MD, Jenny O. Sobera MD, Courtney M. Robbins MD, Wendy C. Cantrell CRNP, Renee A. Desmond DVM PhD, Boni E. Elewski MD
Nail psoriasis can be debilitating and as therapeutic options are limited, it can be notoriously difficult to treat. As there are
many new medications currently undergoing clinical trials in psoriasis, questions have arisen concerning the effectiveness of
these new therapies with regard to psoriatic nail disease. We present the results of a prospective, open-label, proof of concept
study to determine the efficacy and safety of alefacept in subjects with moderate to severe nail psoriasis.